You are here

Sigma-Tau Pharmaceuticals Inc. Offers New Co-Pay Assistance Program for Adagen Patients

October 11, 2012

Sigma-Tau Pharmaceuticals, Inc. announced that it will expand its current patient assistance program to provide financial assistance for patients within the United States who are prescribed ADAGEN® (pegademase bovine) Injection for adenosine deaminase-severe combined immunodeficiency disease (ADA-SCID).

>Click Here to Read More

News Category: